A man fainted during Trump's Oval Office press conference, sparking false claims it was Novo Nordisk executive Gordon Findlay. The company denied it.

Dr Oz soon reached out to help the man when his movement completely faltered and he collapsed in their arms. President Trump was seen immediately rising from his chair in concern. David Ricks stopped his speech midway to turn his attention to the man and ask him if he was alright. He was heard calling the man by the name 'Gordon':

C haos ensued at a White House event on Thursday after a pharmaceutical executive collapsed in the Oval Office during a press conference on a new obesity drug deal. The incident took place shortly after US President Donald Trump announced new price cuts for weight-loss drugs.

"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly,

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce prices. Here's what we know.

In a livestream videos shared by both Forbes and Fox News, Gordon Findlay of Novo Nordisk was seen suddenly collapsing in the Oval Office. According to his LinkedIn, Findlay serves as global brand director of the company, which develops and manufactures GLP-1 drugs like Ozempic.

The man was initially identified as one Gordon Findlay, and many claimed he was a Novo Nordisk executive. “BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended,” an account claimed on X.

The Oval Office announcement was meant to tout the administration's deal on certain weight loss medication prices.

A viral Oval Office video shows Gordon Findlay collapsing, prompting questions about Robert F Kennedy Jr’s response during Trump’s event